Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Fosmanogepix by Basilea Pharmaceutica for Candidiasis: Likelihood of Approval
Fosmanogepix is under clinical development by Basilea Pharmaceutica and currently in Phase II for Candidiasis. According to GlobalData, Phase II...